FDA posts early alert over device used with Impella heart pumps

Johnson & Johnson's Abiomed and manufacturing partner Oscor issued an FDA early alert regarding a bleeding risk from devices used to introduce catheters in Impella heart pump procedures. The alert addresses patient safety concerns with accessory devices.